We welcome Syntegon GmbH as new member to the Drug Delivery Innovation Center.

Syntegon has decades of experience in processing and packaging engineering, research and development. Their technical solutions are high-quality, efficient, and reliable. It is a reliable partner for batch and continuous processing and packaging technology for the pharmaceutical industry. In particular for oral solid dosage forms Syntegon provides their vast know how and portfolio of processing technologies in order to even more empower the DDIC.

The Syntegon Group comprises a worldwide network of centers of excellence and production sites. 1,400 R&D specialists work on developing new technologies or customized applications. Their primary goal is to meet the specific needs of every customer. During their development projects, they maintain close ties with customers and users and regularly incorporate their feedback into the process. For more information, please refer to this link.

The DDIC was founded in 2017 by the companies Bayer AG, LB Bohle GmbH, Merck KGaA (all Germany) and UCB S.A (Belgium), together with the university partners TU Dortmund and HHU Düsseldorf. INVITE GmbH is leading the consortium. The DDIC fosters international, multi-disciplinary networks in the research area of drug delivery and manufacturing, it promotes pharmaceutical science in close collaboration with academia and pharmaceutical industry along the value chain.